Contraline is a biotechnology and medical device company based in Charlottesville, VA focused on developing innovative male contraceptives.
Location: United States, Virginia, Charlottesville
Employees: 1-10
Total raised: $17.9M
Founded date: 2015
Investors 13
Show more
Funding Rounds 2
| Date | Series | Amount | Investors |
| 22.11.2022 | Series A | $7.2M | GV |
| 21.10.2021 | Series A | $10.7M | - |
Mentions in press and media 14
| Date | Title | Description |
| 30.07.2025 | Contraline Exercises License Option for NES/T, the First Male Contraceptive to Reach Late-Stage Development | CHARLOTTESVILLE, VA, UNITED STATES, July 30, 2025 /EINPresswire.com/ -- Contraline, Inc., a clinical-stage biotechnology company developing novel male contraceptives, today announced that it has exercised its option to exclusively license t... |
| 24.04.2025 | Contraline Announces 24-Month Safety and Efficacy Results from First-in-Human Trial of ADAM™ | CHARLOTTESVILLE, VA, UNITED STATES, April 24, 2025 /EINPresswire.com/ -- Contraline, a clinical-stage male contraception company, today announced that participants in the First-in-Human clinical trial of ADAM™ (“The ADAM Study”) have reache... |
| 09.07.2024 | Contraline's First In-Human Trial Shows Safety with 12-Month Efficacy Signals of the ADAM™ Male Contraceptive Device | CHARLOTTESVILLE, VA, UNITED STATES, July 9, 2024 /EINPresswire.com/ -- Contraline, a clinical-stage biotechnology company, has announced promising initial safety and efficacy results from its First-in-Human clinical trial. The trial, which ... |
| 07.05.2024 | Kevin Eisenfrats is developing the ‘male IUD’ | Interest in male birth control has increased in the past few years, especially since the U.S. overturned Roe vs. Wade, which protected a woman’s right to have an abortion. Since then, states have tried to make abortion nearly impossible, pr... |
| 25.04.2024 | Rising infertility concerns fuel growth of male-focused innovative startups | Fertility treatments are more relevant than ever; here are a few startups pioneering new solutions In today’s context of gender-affirming care, puberty blockers have escaped the confines of medical conditions and are now administered to chi... |
| 26.09.2023 | It’s World Contraception Day - And Time to Improve Birth Control: Contraline and TwentyEight Health Share More | In 2016, a two-hormone birth control method for men made headlines. The injection showed promise, but Stage II trial was stopped after an independent review panel found the drug had “too many side effects”, including mood swings and depress... |
| 15.03.2023 | Amboy Street Ventures Launches $20M Fund to Support Femtech Startups | What You Should Know: – Amboy Street Ventures, the world’s first venture capital firm focused on women’s health and sexual health for all genders, closed its debut $20 million fund. – Amboy Street plans to invest in the Seed and Series A st... |
| 10.11.2022 | Contraline Raises $7.2M in Funding | Contraline, a Charlottesville, Virginia-based biotech company producing a long-lasting, contraception for men, raised $7.2M in funding. The round was led by GV with support from Rhia Ventures, ShangBay Capital, Amboy Street Ventures, MBX Ca... |
| 10.11.2022 | Contraline erects $7.2M for contraceptive implants for men | The cervix industry has had implants to prevent pregnancy since the late 1960s, but there hasn’t exactly been stiff competition to slow down the fallopian swim team at its source. In fact, Contraline claims it is the first major innovation ... |
| 21.10.2021 | Contraline Raises $10M in Series A Funding | Contraline, a Charlottesville VA-based medical device company, raised $10M in Series A funding. The round was led by MBX Capital with participation from Rhia Ventures, ShangBay Capital, Founders Fund, Metaplanet Holdings, Graphene Ventures,... |
Show more